Alain Dlubala

This inventor holds 8 USPTO granted patents and 1 published patent application and 6 EPO patents. Top assignees: Sanofi, Sanofi-Aventis. Active years: 2008-2013.

USPTO Granted Patents = 8 (Patent Applications = 1)

% Patents Active = 12.5

EPO Patents = 6 (Patent Applications = 6)

Average Co-Inventor Count = 1.8

ph-index = 2

Forward Citations = 9(Granted Patents)

Location History:

Les Angles, FR (2008 - 2012)
Paris, FR (2012 - 2013)

Company Filing History:

Years Active: 2008-2013

Loading Chart...

8 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8507697 - Photochemical process for producing artemisinin (2013-08-13),

2. 8461122 - Derivatives of morphine-6-glucuronide, preparation method thereof and use of same in therapeutics (2013-06-11),

3. 8455509 - Method for the preparation of morphine compounds (2013-06-04),

4. 8440634 - Bicyclic derivatives of morphine-6-glucuronide, preparation method thereof and use of same in therapeutics (2013-05-14),

5. 8288547 - N-methylnaltrexone zwitterion (2012-10-16),

6. 8258298 - Synthesis of morphine-6-glucuronide or one of the derivatives thereof (2012-09-04),

7. 7645880 - Processs for preparing N-alkylnaltrexone halides (2010-01-12),

8. 7462632 - Method for the preparation of N-piperidino-1, 5-diphenylpyrazole-3-carboxamide derivatives (2008-12-09),

Title: Alain Dlubala: Pioneering Inventor in Renewable Energy Technologies

Introduction:

Alain Dlubala, a visionary inventor based in Paris, FR, has dedicated his career to driving innovation in renewable energy technologies. With a strong commitment to creating a more sustainable future, Alain's passion for innovation has established him as a pioneering figure in the field.

Latest Patents:

Alain Dlubala holds an impressive total of 8 patents, with his latest inventions making significant strides in the realm of renewable energy technologies. One of his recent patents includes a groundbreaking photochemical process for producing artemisinin, offering a novel approach to the synthesis of this crucial compound. Additionally, Alain's work on derivatives of morphine-6-glucuronide showcases his versatility and ingenuity in the field of therapeutics.

Career Highlights:

Throughout his career, Alain Dlubala has made notable contributions to renowned companies such as Sanofi and Sanofi-Aventis. His innovative spirit and tireless dedication to research and development have led to the successful implementation of cutting-edge technologies in the renewable energy sector.

Collaborations:

Alain Dlubala has collaborated closely with talented individuals in the industry, including his esteemed coworkers Claire Trecant and Isabelle Ripoche. Together, they have worked towards advancing renewable energy technologies and pushing the boundaries of innovation in their respective fields.

Conclusion:

Alain Dlubala's exceptional work as an inventor in the renewable energy sector underscores his unwavering commitment to driving positive change through innovation. His groundbreaking patents and collaborative efforts have solidified his reputation as a pioneering figure in the quest for a more sustainable future.